Literature DB >> 20104648

Nicotinamide N-methyltransferase protein expression in renal cell cancer.

Jun Zhang1, Xin-you Xie, Su-wen Yang, Jin Wang, Chao He.   

Abstract

OBJECTIVE: To understand the function of nicotinamide N-methyltransferase (NNMT) protein as tumor biomarker in renal carcinoma.
METHODS: Recombinant NNMT protein was used to prepare monoclonal antibodies by hybridoma technique. The diagnostic and prognostic function of NNMT protein in renal carcinoma was evaluated by analyzing 74 renal cancer tissues through immunohistochemical staining for NNMT by using the prepared antibodies.
RESULTS: Two hybridomas named 2F8 and 1E7 stably secreting the monoclonal antibodies were isolated successfully, and characters such as isotypes and specificity were determined. NNMT protein was significantly up-regulated in renal cancer and significantly associated with tumor histology and ages. The univariate survival analysis demonstrated that the pT-status, high levels of NNMT, and distant metastasis were significant prognosticators.
CONCLUSION: NNMT is over-expressed in a large proportion in renal cell cancers. High NNMT expression is significantly associated with unfavorable prognosis. However, the prognostic value of NNMT needs further verification in larger sample sizes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20104648      PMCID: PMC2816317          DOI: 10.1631/jzus.B0900249

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  26 in total

Review 1.  Disease proteomics.

Authors:  Sam Hanash
Journal:  Nature       Date:  2003-03-13       Impact factor: 49.962

2.  Production and characterization of monoclonal antibodies to nucleoprotein of Marburg virus.

Authors:  Zhang Jibin; Lu Xiumei; Wei Hongping; Cheng Longyan; He Jin; Zhang Zhiping; Zhang Xianen; Yu Ziniu
Journal:  Hybridoma (Larchmt)       Date:  2008-12

3.  Nicotinamide-N-methyltransferase is higher in the lumbar cerebrospinal fluid of patients with Parkinson's disease.

Authors:  K Aoyama; K Matsubara; M Kondo; Y Murakawa; M Suno; K Yamashita; S Yamaguchi; S Kobayashi
Journal:  Neurosci Lett       Date:  2001-01-26       Impact factor: 3.046

Review 4.  Epidemiologic aspects of renal cell cancer.

Authors:  J K McLaughlin; L Lipworth
Journal:  Semin Oncol       Date:  2000-04       Impact factor: 4.929

5.  Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome.

Authors:  Akio Horiguchi; Mototsugu Oya; Tetsuya Shimada; Atsushi Uchida; Ken Marumo; Masaru Murai
Journal:  J Urol       Date:  2002-08       Impact factor: 7.450

6.  Expression of erythropoietin and its receptor in human renal cell carcinoma.

Authors:  Karin Papworth; Anders Bergh; Kjell Grankvist; Börje Ljungberg; Torgny Rasmuson
Journal:  Tumour Biol       Date:  2009-05-04

7.  Stat3 up-regulates expression of nicotinamide N-methyltransferase in human cancer cells.

Authors:  Mikio Tomida; Hideki Ohtake; Takashi Yokota; Yasuhito Kobayashi; Masafumi Kurosumi
Journal:  J Cancer Res Clin Oncol       Date:  2007-10-06       Impact factor: 4.553

8.  Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked?

Authors:  Jie Zhang
Journal:  Bioessays       Date:  2003-08       Impact factor: 4.345

9.  Serum levels of nicotinamide N-methyltransferase in patients with lung cancer.

Authors:  Mikio Tomida; Iwao Mikami; Shingo Takeuchi; Hitoshi Nishimura; Hirohiko Akiyama
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-26       Impact factor: 4.553

10.  Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis.

Authors:  Jongmin Kim; Seok Joo Hong; Eun Kyung Lim; Yun-Suk Yu; Seung Whan Kim; Ji Hyeon Roh; In-Gu Do; Jae-Won Joh; Dae Shick Kim
Journal:  J Exp Clin Cancer Res       Date:  2009-02-16
View more
  12 in total

1.  Nicotinamide N-methyltransferase: a potential biomarker for worse prognosis in gastric carcinoma.

Authors:  Chen Chen; Xin Wang; Xing Huang; Hongmei Yong; Jiajia Shen; Qi Tang; Jin Zhu; Jian Ni; Zhenqing Feng
Journal:  Am J Cancer Res       Date:  2016-02-15       Impact factor: 6.166

2.  Physiological Study on Association between Nicotinamide N-Methyltransferase Gene Polymorphisms and Hyperlipidemia.

Authors:  Xiao-Juan Zhu; Ya-Jun Lin; Wei Chen; Ya-Hui Wang; Li-Qiang Qiu; Can-Xin Cai; Qun Xiong; Fei Chen; Li-Hui Chen; Qiong Zhou; Jiang-Hua Li
Journal:  Biomed Res Int       Date:  2016-11-23       Impact factor: 3.411

3.  Nicotinamide N-methyltransferase enhances resistance to 5-fluorouracil in colorectal cancer cells through inhibition of the ASK1-p38 MAPK pathway.

Authors:  Xinyou Xie; Huixing Liu; Yanzhong Wang; Yanwen Zhou; Haitao Yu; Guiling Li; Zhi Ruan; Fengying Li; Xiuhong Wang; Jun Zhang
Journal:  Oncotarget       Date:  2016-07-19

Review 4.  Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects.

Authors:  Abdulla A-B Badawy
Journal:  Int J Tryptophan Res       Date:  2017-03-15

5.  Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior.

Authors:  Aaron Mobley; Shizhen Zhang; Jolanta Bondaruk; Yan Wang; Tadeusz Majewski; Nancy P Caraway; Li Huang; Einav Shoshan; Guermarie Velazquez-Torres; Giovanni Nitti; Sangkyou Lee; June Goo Lee; Enrique Fuentes-Mattei; Daniel Willis; Li Zhang; Charles C Guo; Hui Yao; Keith Baggerly; Yair Lotan; Seth P Lerner; Colin Dinney; David McConkey; Menashe Bar-Eli; Bogdan Czerniak
Journal:  Sci Rep       Date:  2017-01-19       Impact factor: 4.379

6.  Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization.

Authors:  Yanzhong Wang; Jin Zeng; Weiping Wu; Shuduo Xie; Haitao Yu; Guoli Li; Tao Zhu; Fengying Li; Jie Lu; Gavin Y Wang; Xinyou Xie; Jun Zhang
Journal:  Breast Cancer Res       Date:  2019-05-17       Impact factor: 6.466

Review 7.  Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review.

Authors:  Lucrezia Togni; Marco Mascitti; Davide Sartini; Roberto Campagna; Valentina Pozzi; Eleonora Salvolini; Annamaria Offidani; Andrea Santarelli; Monica Emanuelli
Journal:  Biomolecules       Date:  2021-10-28

8.  Prognostic value of nicotinamide N-methyltransferase in human cancers: Evidence from a meta-analysis and database validation.

Authors:  Ling Dang; Yingdong Wang
Journal:  Open Med (Wars)       Date:  2022-02-14

9.  Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling.

Authors:  A Atrih; M A V Mudaliar; P Zakikhani; D J Lamont; J T-J Huang; S E Bray; G Barton; S Fleming; G Nabi
Journal:  Br J Cancer       Date:  2014-02-18       Impact factor: 7.640

10.  Down-regulation of nicotinamide N-methyltransferase induces apoptosis in human breast cancer cells via the mitochondria-mediated pathway.

Authors:  Jun Zhang; Yanzhong Wang; Guiling Li; Haitao Yu; Xinyou Xie
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.